CI | Ticker Profile - Titan Protect

Cigna

Health Care · Health Care Services · US

$289.48

Data: 2026-05-15

✓ ETHICAL PASS

WEAK MOAT

HIGH

Data Confidence: 100.0%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$76.0B

Total market value of the company

Trailing P/E

11.55

Reasonably valued

Forward P/E

8.57

Based on estimated future earnings — lower means cheaper

Rev Growth

+4.6%

Year-over-year revenue change

Profit Margin

2.3%

How much profit the company keeps from each dollar of revenue

ROE

16.3%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$340.50

+18% from current price — median analyst estimate

Recommendation

STRONG_BUY

Consensus view from 24 analysts covering this stock

About Cigna

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations. The company offers other operations, including corporate-owned life insurance, reinsurance, and certain run-off and non-strategic businesses. The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

https://www.thecignagroup.com

Country: United States Employees: 65,669 Industry: Healthcare Plans

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

19.9% PASS

Debt must be below 33% of total assets

Cash Ratio

2.2% PASS

Interest-bearing cash below 33% of assets

Receivables

23.1% PASS

Receivables below 49% of assets

Revenue Purity

0.0% PASS

Non-compliant revenue below 5% — any excess requires purification

Valuation

Fair Value Est.

$402.56

What our model estimates this business is worth per share

Margin of Safety

28.1%

Trading below fair value — margin of safety exists

Rating

OPPORTUNITY

Overall assessment combining ethics, valuation, and quality

Percentile

98.2th

Ranks in the top 2% of our 13,571 screened universe

Ethical Score

85.8

Valuation Score

90.5

Quality Score

54.3

Combined

76.4

Trading at $287 against a fair value of $403, a 29% discount. Passes all ethical screens. Ranks better than 93% of screened stocks.

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

MARKUP

Price trending up with increasing momentum

Sharpe Ratio

-0.065

Returns do not compensate for the risk — negative edge

Kelly Fraction

-0.0063

No positive edge detected — the data suggests staying out

Calmar Ratio

-0.202

Drawdown risk outweighs the returns — higher risk profile

Annual Return

-6.5%

Historical annualised return based on price data

Max Drawdown

-32.1%

Largest peak-to-trough decline — the worst it has been

HMM State

BULL

Statistical model sees bullish momentum

Days in State

121

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

0.31

Very low correlation to market moves

52W High

$338.89

15% below the year high

52W Low

$239.51

21% above the year low

Avg Volume

1,674,306

Average daily shares traded — higher means easier to buy and sell

Short Ratio

4.3

Days it would take all short sellers to cover — higher means more crowded

Short % Float

2.7%

Low short interest — limited bearish positioning

Div Yield

2.1%

Annual dividend as a percentage of the share price

EPS (TTM)

$24.31

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

0.73

Moderate leverage — manageable

Current Ratio

0.82

Below 1 means short-term obligations exceed liquid assets — risk flag

Quick Ratio

0.66

Like current ratio but excludes inventory — stricter test

Gross Margin

9.1%

Revenue left after cost of goods — higher means pricing power

Operating Margin

5.5%

Profit from core operations before interest and tax

Free Cash Flow

$6.9B

Positive — the business generates more cash than it spends

Revenue (TTM)

$277.9B

Total revenue over the last 12 months

Net Income

$6.3B

Profitable — the bottom line is positive

Analyst Coverage

Analysts

Target High

$378.00

Target Median

$340.50

Target Low

$290.00

Recent Insider Activity

SEC Form 4 filings — what company insiders are buying and selling

45

NEUTRAL

Mixed insider activity. 0 purchases and 0 sales in the last 90 days — no clear directional signal. Political selling noted.

Date	Insider	Title	Shares	Value
2026-05-13	CORDANI DAVID M	Chief Executive Officer	212,543	$36,205,221
2026-05-12	CORDANI DAVID M	Chief Executive Officer	201,878	$59,114,186
2026-04-22	MAZZARELLA KATHLEEN M.	Director	782	—
2026-04-22	FOSS ERIC J.	Director	782	—
2026-04-22	ZARCONE DONNA F	Director	782	—
2026-04-22	HENNIGAN MICHAEL J	Director	782	—
2026-04-22	WISEMAN ERIC C	Director	782	—
2026-04-22	KURIAN GEORGE	Director	782	—
2026-04-22	MCCLELLAN MARK B	Director	782	—
2026-04-22	ROSS KIMBERLY A	Director	782	—

Source: SEC Form 4 filings via public data. View all insider activity at

Insider Intelligence

Political Trading Activity

Congressional trading disclosures involving this instrument

Date	Politician	Party	Type	Amount
9 Apr2026	Josh Gottheimer	Democrat	sell	1K–15K
9 Apr2026	Josh Gottheimer	Democrat	sell	15K–50K
9 Apr2026	Scott Peters	Democrat	buy	50K–100K
9 Apr2026	Scott Peters	Democrat	sell	500K–1M
8 Apr2026	Mike Kelly	Republican	buy	50K–100K

Source: Congressional disclosure filings. View all political trades at

Insider Intelligence

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-15

Before you go